Concepedia

Publication | Open Access

1300: Efficacy and safety of BI 1482694 (HM61713), an EGFR mutant-specific inhibitor, in T790M-positive NSCLC at the recommended phase II dose

DOIFull Paper Access

38

Citations

0

References

2016

Year

K. Park, J.-S. Lee, J. Y. Han, K.H. Lee, Jee Hyun Kim, E. K. Cho, Jungwon Cho, Young Joo Min, Jung‐Sun Kim, D.-W. Kim
Journal of Thoracic Oncology

No additional data available for this publication yet. Check back later!